Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (Partners) and CME Science. Partners is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Advanced Breast Imaging: Current Diagnosis and Work Up of Problematic Breast Cases
Credit Designation - ACCME and Objectives
Partners designates each of these live activities for a maximum of 16.5-17.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Advanced Breast Imaging: Current Diagnosis and Work Up of Problematic Breast Cases, March 19-20, 2026 - 16.5 hours
Advanced Breast Imaging: Current Diagnosis and Work Up of Problematic Breast Cases, October 22-23, 2026 - 17.5 hours
3 Years of Requirements in 2 Days
Meet all of your MQSA CME requirements, as well as Breast MR CME requirements for ACR accreditation. We will cover digital mammography, breast MRI, breast ultrasound, tomosynthesis, interventional practices, breast cancer, lymph nodes, high risk lesions, BIRADS, implants, screening, risk management and more
At the conclusion of this activity, participants should be able to:
- Optimize imaging methods to reduce the number of false-positive mammography interpretations.
- Describe recent advances and techniques in breast imaging.
- Integrate information presented in this course into efforts to improve the imaging skills of the participants.
BI-RADS® v2025: What’s Changed, What Matters, and How to Apply It
Credit Designation - ACCME and Objectives
Partners designates this live activity for a maximum of 8.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
BIRADS
Course Objectives
Upon completion of this activity, participants should be able to:
-
Optimize breast imaging interpretation and reporting by incorporating the key updates and revisions introduced in BI-RADS® v2025 across mammography, ultrasound, MRI, DBT, and CEM.
-
Describe the major changes to BI-RADS® terminology, descriptors, and assessment categories introduced in v2025 and their impact on clinical decision-making.
-
Utilize the updated BI-RADS® v2025 lexicon to improve report clarity, consistency, and communication with referring clinicians.
-
Implement BI-RADS® v2025 recommendations into daily clinical workflows, including structured reporting and follow-up management.
-
Identify common interpretive challenges and potential pitfalls associated with the transition to BI-RADS® v2025 and strategies to minimize variability among readers.
-
Use updated BI-RADS® v2025 guidance to assign appropriate assessment categories and management recommendations across multiple breast imaging modalities.
-
Explain the implications of BI-RADS® v2025 updates on quality assurance, auditing, and outcomes tracking within breast imaging practices.
-
Outline practical steps for transitioning an imaging practice from prior BI-RADS® editions to BI-RADS® v2025, including communication with technologists and clinical teams.
-
Apply BI-RADS® v2025 standards through case-based examples to enhance diagnostic accuracy and confidence in real-world clinical scenarios.
Target Audience
This course is intended for Practicing Radiologists and Radiologic Nurses, Physician Assistants, Technologists, Scientists, Residents, Fellows and others who are interested in current techniques and applications for breast imaging.
Disclosure of Conflicts of Interest
Partners requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships are mitigated according to PACE policies.
Technologist Credit - ARRT
ARRT Category A CE credit will be awarded to technologists attending the full course as follows
Advanced Breast Imaging: Current Diagnosis and Work Up of Problematic Breast Cases, March 19-20, 2026 - 16.5 hours
BI-RADS® v2025: What’s Changed, What Matters, and How to Apply It, May 2, 2026 - 8.0 hours
Advanced Breast Imaging: Current Diagnosis and Work Up of Problematic Breast Cases, October 22-23, 2026 - 17.5 hours
CME Certificate Inquiries and Modality Breakout Letters
CME Certificate Copies for 2023-2025
To retrieve your CME certificate from Partners please login to your account on http://www.partnersed.com/. Information on how to complete the evaluation for the course you registered for was sent via email post course. If you need assistance with PACE's website please contact customersupport@cealliance.com. If you need course specific claiming information, please email info@cmescience.com.
CEU Certificate inquires for Technologists please contact:
Toni at toni@cmescience.com
Faculty
The faculty members have nothing to disclose.
Planners and Managers
The Partners planners and managers have nothing to disclose. The CME Science planners and managers have nothing to disclose.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
ADA Act
Event staff will be glad to assist you with any special needs (i.e., physical, medically necessary dietary, etc). Please contact CME Science prior to the live event at info@cmescience.com.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
